STOCK TITAN

MariMed Announces First Quarter 2023 Earnings Date

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

MariMed Inc. (CSE: MRMD, OTCQX: MRMD), a leading multi-state cannabis operator, will report its Q1 2023 financial results on May 8, 2023, after market close. Management will host a conference call on May 9, 2023, at 8:00 a.m. EST to discuss the financial outcomes. The call will be accessible via a webcast on MariMed’s Investor Relations website, where a playback will also be available. MariMed is dedicated to improving lives through its high-quality cannabis products, utilizing state-licensed facilities and proprietary formulations that underpin its popular brands such as Betty's Eddies and Nature’s Heritage.

Positive
  • Upcoming Q1 2023 financial results report on May 8, 2023, indicating transparency.
  • Management conference call scheduled for May 9, 2023, allowing for direct investor communication.
Negative
  • None.

NORWOOD, Mass., April 11, 2023 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”), (CSE: MRMD), (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced it will report its first quarter 2023 financial results on May 8, 2023 after the markets close. Management will host a conference call on May 9, 2023 at 8:00 a.m. EST to discuss financial results.

A webcast will be available and can be accessed via MariMed’s Investor Relations website at MariMed Q123 Earnings Webcast. A playback of the call will be made available on MariMed’s Investor Relations website.

About MariMed
MariMed Inc., a multi-state cannabis operator, is dedicated to improving lives every day through its high-quality products, its actions, and its values. The Company develops, owns, and manages seed to sale state-licensed cannabis facilities, which are models of excellence in horticultural principles, cannabis cultivation, cannabis-infused products, and dispensary operations. MariMed has an experienced management team that has produced consistent growth and success for the Company and its managed business units. Proprietary formulations created by the Company’s technicians are embedded in its top-selling and award-winning products and brands, including Betty's Eddies, Nature’s Heritage, InHouse, Bubby’s Baked, K Fusion, Kalm Fusion, and Vibations: High + Energy. For additional information, visit www.marimedinc.com.

Investor Relations Contact:
Steve West
Vice President, Investor Relations
Email: ir@marimedinc.com
Phone: (781) 277-0007

Company Contact:
Howard Schacter
Chief Communications Officer
Email: hschacter@marimedinc.com
Phone: (781) 277-0007


FAQ

When will MariMed report its Q1 2023 financial results?

MariMed will report its Q1 2023 financial results on May 8, 2023, after market close.

What time is the MariMed conference call for financial results?

The conference call to discuss MariMed's financial results is scheduled for May 9, 2023, at 8:00 a.m. EST.

Where can I access the MariMed earnings webcast?

The earnings webcast can be accessed via MariMed’s Investor Relations website.

MARIMED INC

OTC:MRMD

MRMD Rankings

MRMD Latest News

MRMD Stock Data

64.32M
342.15M
14.01%
0.79%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Norwood